Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Arterial Hypertension PAH”

889 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 889 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04175600
What this trial is testing

Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Actelion 138
Not applicableStudy completedNCT05812976
What this trial is testing

Novel Index (PIMR) in PAH

Who this might be right for
Pulmonary Hypertension
University of California, Los Angeles 22
Large-scale testing (Phase 3)Ended earlyNCT00796510
What this trial is testing

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 3
Not applicableStudy completedNCT01043627
What this trial is testing

Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)

Who this might be right for
Pulmonary Arterial Hypertension
Mayo Clinic 100
Large-scale testing (Phase 3)Study completedNCT02471183
What this trial is testing

Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 34
Post-approval studies (Phase 4)Ended earlyNCT00458042
What this trial is testing

Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction

Who this might be right for
Hypertension, Pulmonary
United Therapeutics 10
Not applicableStudy completedNCT01581086
What this trial is testing

Vascular Subphenotypes of Lung Disease in HIV & COPD

Who this might be right for
Pulmonary Artery Hypertension
University of Pittsburgh 30
Not applicableStudy completedNCT05339386
What this trial is testing

Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Kansas Medical Center 10
Large-scale testing (Phase 3)Ended earlyNCT03657095
What this trial is testing

A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 112
Not applicableStudy completedNCT02799771
What this trial is testing

HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION

Who this might be right for
Pulmonary Arterial HypertensionDiffuse Interstitial Lung Disease
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 210
Not applicableUnknownNCT05587400
What this trial is testing

Consistency of Electrical Cardiometry and Pulmonary Artery Catheter

Who this might be right for
Pulmonary Arterial HypertensionRight Ventricular Dysfunction
Shanghai Zhongshan Hospital 199
Large-scale testing (Phase 3)Study completedNCT01142219
What this trial is testing

L-Arginine and Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Hospital de Clinicas de Porto Alegre 40
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Testing effectiveness (Phase 2)Study completedNCT02276872
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

Who this might be right for
PAH
United Therapeutics 32
Testing effectiveness (Phase 2)Study completedNCT02032836
What this trial is testing

Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 27
Large-scale testing (Phase 3)Study completedNCT01908699
What this trial is testing

Beraprost-314d Added-on to Tyvaso® (BEAT)

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 273
Not applicableStudy completedNCT04745000
What this trial is testing

Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension

Who this might be right for
Hypertension;Pulmonary;Primary
University of Colorado, Denver 43
Not applicableNot Yet RecruitingNCT07082933
What this trial is testing

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Xijing Hospital 5,000
Early research (Phase 1)WithdrawnNCT05731492
What this trial is testing

Macitentan in Children Below 2 Years of Age

Who this might be right for
Arterial Hypertension, Pulmonary
Actelion
Large-scale testing (Phase 3)Study completedNCT02042014
What this trial is testing

Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan

Who this might be right for
Severe Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 8
Next Page